Recombinant fowlpox virus inducing protective immunity in non-avian species
- PMID: 2854338
- DOI: 10.1016/0264-410x(88)90100-4
Recombinant fowlpox virus inducing protective immunity in non-avian species
Abstract
The natural host of fowlpox virus is limited to avian species. When inoculated into non-avian tissue culture cells, however, fowlpox virus can initiate an abortive infection. A fowlpox virus was engineered to express rabies virus glycoprotein. On inoculation of the recombinant virus into either avian (permissive) or non-avian (non-permissive) cells, the rabies glycoprotein was expressed as a membrane-associated antigen. Inoculation of the fowlpox virus recombinant into six different species of mammal resulted in specific immune responses to both fowlpox antigens and to rabies glycoprotein. In mice, cats and dogs the immune response was sufficient to protect against a live rabies virus challenge. The results demonstrate the utility of a fowlpox virus vector in immunizing non-avian species against rabies in the absence of productive viral replication of the fowlpox vector.
Similar articles
-
Protective immunity against avian influenza induced by a fowlpox virus recombinant.Vaccine. 1988 Dec;6(6):504-8. doi: 10.1016/0264-410x(88)90101-6. Vaccine. 1988. PMID: 2854339
-
Fowlpox virus as a vector in non-avian species.Vaccine. 1988 Dec;6(6):466-8. doi: 10.1016/0264-410x(88)90091-6. Vaccine. 1988. PMID: 2854335
-
Efficacy studies on a canarypox-rabies recombinant virus.Vaccine. 1991 Mar;9(3):190-3. doi: 10.1016/0264-410x(91)90152-v. Vaccine. 1991. PMID: 2042391
-
Applications of pox virus vectors to vaccination: an update.Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11349-53. doi: 10.1073/pnas.93.21.11349. Proc Natl Acad Sci U S A. 1996. PMID: 8876138 Free PMC article. Review.
-
Development and use of fowlpox vectored vaccines for avian influenza.Ann N Y Acad Sci. 2006 Oct;1081:193-201. doi: 10.1196/annals.1373.023. Ann N Y Acad Sci. 2006. PMID: 17135511 Review.
Cited by
-
Construction of a pigeonpox virus recombinant: expression of the Newcastle disease virus (NDV) fusion glycoprotein and protection of chickens against NDV challenge.Arch Virol. 1991;118(1-2):43-56. doi: 10.1007/BF01311302. Arch Virol. 1991. PMID: 1646592
-
Characterization of host responses against a recombinant fowlpox virus-vectored vaccine expressing the hemagglutinin antigen of an avian influenza virus.Clin Vaccine Immunol. 2010 Mar;17(3):454-63. doi: 10.1128/CVI.00487-09. Epub 2010 Jan 13. Clin Vaccine Immunol. 2010. PMID: 20071494 Free PMC article.
-
Construction and characterisation of a recombinant fowlpox virus that expresses the human papilloma virus L1 protein.J Transl Med. 2011 Nov 4;9:190. doi: 10.1186/1479-5876-9-190. J Transl Med. 2011. PMID: 22053827 Free PMC article.
-
Non-replicating expression vectors: applications in vaccine development and gene therapy.Epidemiol Infect. 1996 Jun;116(3):241-56. doi: 10.1017/s0950268800052547. Epidemiol Infect. 1996. PMID: 8666067 Free PMC article. Review.
-
Enhanced Expression of the L1R Gene of Vaccinia Virus by the tPA Signal Sequence Inserted in a Fowlpox-Based Recombinant Vaccine.Vaccines (Basel). 2024 Sep 29;12(10):1115. doi: 10.3390/vaccines12101115. Vaccines (Basel). 2024. PMID: 39460282 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous